Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather H Cheng

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Abdominal Radiology (New York)|February 22, 2024
Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applicationsShamus Moran, Heather H Cheng, Emily Weg, et al.
European Urology Oncology|December 5, 2024
Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate CancerFrancesca Zacchi, Wassim Abida, Emmanuel S Antonarakis, et al.
Medical Oncology (Northwood, London, England)|June 15, 2016
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Elahe A Mostaghel, et al.
The Prostate|May 31, 2021
Barriers and facilitators of germline genetic evaluation for prostate cancerStacy Loeb, Randall Li, Tatiana Sanchez Nolasco, et al.
JCO Precision Oncology|October 15, 2021
Adopting Consensus Terms for Testing in Precision MedicineNikki A Martin, Joel E Tepper, Veda N Giri, et al.
JCO Precision Oncology|July 14, 2022
<i>BRCA2</i> Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case SeriesLynn Symonds, Erik Konnick, Funda Vakar-Lopez, et al.
The Prostate|July 11, 2018
Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survivalDaniel M Lim, Roman Gulati, Serge Aleshin-Guendel, et al.
European Urology|September 21, 2024
Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic ReviewEdoardo Francini, Neeraj Agarwal, Elena Castro, et al.
Plos One|May 27, 2020
Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapiesLaura S Graham, Bruce Montgomery, Heather H Cheng, et al.
European Urology|February 25, 2019
Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM MutationsCatherine H Marshall, Alexandra O Sokolova, Andrea L McNatty, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Abdominal Radiology (New York)|February 22, 2024
Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applicationsShamus Moran, Heather H Cheng, Emily Weg, et al.
European Urology Oncology|December 5, 2024
Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate CancerFrancesca Zacchi, Wassim Abida, Emmanuel S Antonarakis, et al.
Medical Oncology (Northwood, London, England)|June 15, 2016
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Elahe A Mostaghel, et al.
The Prostate|May 31, 2021
Barriers and facilitators of germline genetic evaluation for prostate cancerStacy Loeb, Randall Li, Tatiana Sanchez Nolasco, et al.
JCO Precision Oncology|October 15, 2021
Adopting Consensus Terms for Testing in Precision MedicineNikki A Martin, Joel E Tepper, Veda N Giri, et al.
JCO Precision Oncology|July 14, 2022
<i>BRCA2</i> Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case SeriesLynn Symonds, Erik Konnick, Funda Vakar-Lopez, et al.
The Prostate|July 11, 2018
Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survivalDaniel M Lim, Roman Gulati, Serge Aleshin-Guendel, et al.
European Urology|September 21, 2024
Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic ReviewEdoardo Francini, Neeraj Agarwal, Elena Castro, et al.
Plos One|May 27, 2020
Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapiesLaura S Graham, Bruce Montgomery, Heather H Cheng, et al.
European Urology|February 25, 2019
Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM MutationsCatherine H Marshall, Alexandra O Sokolova, Andrea L McNatty, et al.
Pageof 15